Arrow - Quinapril 10

Kraj: Nowa Zelandia

Język: angielski

Źródło: Medsafe (Medicines Safety Authority)

Kup teraz

Pobierz Ulotka dla pacjenta (PIL)
19-04-2020

Składnik aktywny:

Quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril;  ; Quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril

Dostępny od:

Teva Pharma (New Zealand) Limited

INN (International Nazwa):

Quinapril hydrochloride 10.85 mg (equivalent to 10 mg quinapril)

Dawkowanie:

10 mg

Forma farmaceutyczna:

Film coated tablet

Skład:

Active: Quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril   Excipient: Crospovidone Heavy magnesium carbonate Hyprolose Isopropyl alcohol Macrogol 6000 Magnesium stearate Methacrylic acid copolymer Purified talc Titanium dioxide Active: Quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril Excipient: Crospovidone Heavy magnesium carbonate Hyprolose Isopropyl alcohol Macrogol 6000 Magnesium stearate Methacrylic acid copolymer Purified talc Titanium dioxide

Sztuk w opakowaniu:

Blister pack, polyamide-Al foil-PVC/Al foil, 30 tablets

Klasa:

Prescription

Typ recepty:

Prescription

Wyprodukowano przez:

Rolabo Outsourcing SL

Wskazania:

Quinapril is indicated for the treatment of essential hypertension. Quinapril is effective as monotherapy or concomitantly with diuretics and beta-blockers in patients with hypertension. Quinapril is effective in the treatment of congestive heart failure when given concomitantly with a diuretic and/or digoxin.

Podsumowanie produktu:

Package - Contents - Shelf Life: Blister pack, polyamide-Al foil-PVC/Al foil - 30 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, polyamide-Al foil-PVC/Al foil - 90 tablets - 24 months from date of manufacture stored at or below 25°C

Data autoryzacji:

2005-04-29

Ulotka dla pacjenta

                                CONSUMER MEDICINE INFORMATION
ARROW - QUINAPRIL
QUINAPRIL 5 MG, 10 MG, 20 MG TABLETS
WHAT IS IN THIS LEAFLET
This leaflet answers some common questions about ARROW - QUINAPRIL.
It does not contain all of the available information. It does not take
the place of
talking to your doctor or pharmacist.
All medicines have benefits and risks. Your doctor has weighed the
risks of
you taking ARROW - QUINAPRIL against the benefits they expect it will
have
for you.
If you have any concerns about taking this medicine, talk to your
doctor or
pharmacist.
Keep this leaflet with your medicine. You may need to read it again.
WHAT ARROW - QUINAPRIL IS USED FOR
ARROW - QUINAPRIL is used to lower high blood pressure (hypertension).
It
is also used to treat heart failure.
HYPERTENSION
ARROW – QUINAPRIL is used to lower high blood pressure
(hypertension).
Everyone has blood pressure. This pressure helps get your blood all
around
your body.
Your blood pressure may be different at different times of the day,
depending
on how busy or worried you are. You have hypertension (high blood
pressure)
when your blood pressure stays higher than is needed even when you are
calm and relaxed.
There are usually no symptoms of hypertension. The only way of knowing
that you have hypertension is to have your blood pressure checked on a
regular basis. If high blood pressure is not treated it can lead to
serious
health problems, including stroke, heart disease and kidney failure.
HEART FAILURE
Heart failure means that the heart muscle cannot pump blood strongly
enough
to supply all the blood needed throughout the body. Heart failure is
not the
same as heart attack and does not mean that the heart stops.
Heart failure may start off with no symptoms, but as the condition
progresses,
patients may feel short of breath or may get tired easily after light
physical
activity such as walking. Some patients may wake up short of breath at
night.
Fluid may collect in different parts of the body, often first noticed
as swollen
ankles and feet.
ARROW – QUINAPRIL wo
                                
                                Przeczytaj cały dokument
                                
                            

Charakterystyka produktu

                                NEW ZEALAND DATA SHEET
Version 1.1
Page 1 of 19
1.
NAME OF THE MEDICINE
Arrow – Quinapril 5, film-coated tablets, 5 mg
Arrow – Quinapril 10, film-coated tablets, 10 mg
Arrow – Quinapril 20, film-coated tablets, 20 mg
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 5 mg, 10 mg or 20 mg of quinapril as quinapril
hydrochloride.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablets 5 mg: Yellow, oval, biconvex film coated tablets, one side
scored and embossed ‘5’ on the
other side.
Tablets 10 mg: White to almost white, round, biconvex film coated
tablets, one side scored and
embossed ‘10’ on the other side.
Tablets 20 mg: Yellow, round, biconvex film coated tablets, one side
scored and embossed ‘20’ on the
other side.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
HYPERTENSION
Quinapril
is
indicated
for
the
treatment
of
essential
hypertension.
Quinapril
is
effective
as
monotherapy or concomitantly with diuretics and beta-blockers in
patients with hypertension.
CONGESTIVE HEART FAILURE
Quinapril is effective in the treatment of congestive heart failure
when given concomitantly with a
diuretic and/or digoxin.
4.2
DOSE AND METHOD OF ADMINISTRATION
HYPERTENSION IN ADULTS
MONOTHERAPY
The recommended initial dosage of quinapril in patients not on
diuretics is 10 mg once daily.
Depending upon clinical response, the patient's dosage may be titrated
(by doubling the dose) to a
maintenance dosage of 20 mg to 40 mg/day given as a single dose or
divided into two doses.
Generally dosage adjustments should be made at intervals of four
weeks. Long-term control is
maintained in most patients with a single daily dosage regimen.
Patients have been treated with
dosages of quinapril up to 80 mg/day.
CONCOMITANT DIURETICS
In patients who are also being treated with a diuretic, the initial
dosage of quinapril should not exceed
5 mg in order to determine if excess hypotension will occur. The
dosage should subsequently be
titrated (as described above) to the optimal response
                                
                                Przeczytaj cały dokument
                                
                            

Zobacz historię dokumentów